Get my own profile
Public access
View all26 articles
1 article
available
not available
Based on funding mandates
Co-authors
Bernd KuhnF. Hoffmann-La RocheVerified email at roche.com
Rainer E. MartinF. Hoffmann-La Roche LtdVerified email at roche.com
Herbert WaldmannMax-Planck-Institut DortmundVerified email at mpi-dortmund.mpg.de
Roger SchibliETH Zurich and Paul Scherrer Institute, SwitzerlandVerified email at pharma.ethz.ch
Kenneth AtzAI Scientist at Roche | PhD AI/ML ETH ZürichVerified email at ethz.ch
Dr. Franz SchulerF. Hoffmann-La Roche Ltd.Verified email at roche.com
Markus G. RudolphF. Hoffmann-La Roche, Therapeutic ModalitiesVerified email at roche.com
Marc NazareGroup leader, Leibniz-Forschungsinstitut für Molekulare (FMP)Verified email at fmp-berlin.de
Mario van der SteltLeiden UniversityVerified email at chem.leidenuniv.nl
Robert Narquizian, PhD, MBAHarvard University ; Glasgow university; London Business School, Roche; LillyVerified email at eccogene.com
Pal PacherNational Institutes of Health, BethesdaVerified email at mail.nih.gov
Dmitry VeprintsevProfessor of Molecular and Cellular Pharmacology, University of NottinghamVerified email at nottingham.ac.uk
David F. NippaScientist @ RocheVerified email at roche.com
Gisbert SchneiderETH ZurichVerified email at ethz.ch
Yingfang HePhD candidate, ETH ZurichVerified email at pharma.ethz.ch
Dr David Andrew SykesUniversity of NottinghamVerified email at nottingham.ac.uk
Thais GazziETH ZurichVerified email at org.chem.ethz.ch
Laura HeitmanFull Professor of Molecular PharmacologyVerified email at lacdr.leidenuniv.nl
Roman C. SarottSNSF Postdoctoral Fellow, Stanford UniversityVerified email at stanford.edu
Arne RuferF. Hoffmann-La Roche LtdVerified email at roche.com